Credit: UT Southwestern
A study led by Dr. Phillip Scherer (l-r), Jonathan Xia, and Dr. William Holland determined that reducing concentrations of the fatty molecule ceramide improves insulin sensitivity, offering potential as a new therapy for diabetes.